FOLD vs. USMV

In the year-to-date period, FOLD achieves a -35.56% return, which is significantly lower than USMV's 5.68% return. Over the past 10 years, FOLD has underperformed USMV with an annualized return of -6.76%, while USMV has yielded a comparatively higher 10.54% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Amicus Therapeutics, Inc. (FOLD) and iShares Edge MSCI Min Vol USA ETF (USMV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FOLD Sharpe Ratio is -0.94, which is lower than the USMV Sharpe Ratio of 1.25. The chart below compares the historical Sharpe Ratios of FOLD and USMV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FOLD has not paid dividends to shareholders, while USMV's dividend yield for the trailing twelve months is around 1.55%.

The maximum FOLD drawdown since its inception was -89.91%, which is greater than USMV's maximum drawdown of -33.10%. Use the drawdown chart below to compare losses from any high point for FOLD and USMV.

Amicus Therapeutics, Inc. (FOLD) has a higher volatility of 18.76% compared to iShares Edge MSCI Min Vol USA ETF (USMV) at 3.55%. This indicates that FOLD's price experiences larger fluctuations and is considered to be riskier than USMV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.